Analgesics in Australia

Euromonitor International's Analgesics in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: adult analgesics, child-specific analgesics, systemic analgesics, topical analgesics

Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

• Get a detailed picture of the analgesics industry
• Pinpoint growth sectors and trends and identify factors driving change
• Understand the competitive environment, the market's major players and leading brands
• Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilniuis, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.

• Analgesics in Australia
• Euromonitor International
• May 2009
• OTC Healthcare Continues To Grow Steadily
• Symbion Health Ltd Undergoes Multiple Acquisitions
• Symbion Health Ltd Retains Lead in OTC Healthcare
• Retail Pressure Heat Up As Grocery Retailers Continue To Strengthen
• Moderate Growth Expected Over Forecast Period
• Key Trends and Developments
• Convenience Featuring Highly in Both Product Development and Distribution
• Preference for Branded Products Over Generics and Private Label
• Child-specific Products Experience Growth
• Negative Publicity Associated With Side Effects of OTC Healthcare
• Rising Retail Pressures for Chemists/pharmacies
• Market Indicators
• Market Data
• OTC Registration and Classification
• Vitamins and Dietary Supplements Registration and Classification
• Self-medication and Preventative Medicine
• Generics
• Switches
• Definitions
• Ego Pharmaceuticals Pty Ltd
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Herron Pharmaceuticals Pty Ltd
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Inova Pharmaceuticals (australia) Pty Ltd
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Pharmacare Laboratories Pty Ltd
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Symbion Health Ltd
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Headlines
• Trends
• Switches
• Competitive Landscape
• Prospects
• Sector Data
• List of Summaries
  • Summary 1 OTC Healthcare Switches 2005-2008
  • Summary 2 Research Sources
  • Summary 3 Ego Pharmaceuticals Pty Ltd: Key Facts
  • Summary 4 Ego Pharmaceuticals Pty Ltd: Competitive Position 2008
  • Summary 5 Herron Pharmaceuticals Pty Ltd: Key Facts
  • Summary 6 Herron Pharmaceuticals Pty Ltd: Competitive Position 2008
  • Summary 7 iNova Pharmaceuticals (Australia) Pty Ltd: Key Facts
  • Summary 8 iNova Pharmaceuticals (Australia) Pty Ltd: Production Statistics 2008
  • Summary 9 iNova Pharmaceuticals (Australia) Pty Ltd: Competitive Position 2008
  • Summary 10 Pharmacare Laboratories Pty Ltd: Key Facts
  • Summary 11 Pharmacare Laboratories Pty Ltd: Competitive Position 2008
  • Summary 12 Symbion Health Ltd: Key Facts
  • Summary 13 Symbion Health Ltd: Operational Indicators
  • Summary 14 Symbion Health Ltd: Production Statistics 2008
  • Summary 15 Symbion Health Ltd: Competitive Position 2008
• List of Tables
  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
  • Table 2 Life Expectancy at Birth 2003-2008
  • Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
  • Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
  • Table 5 OTC Healthcare Company Shares by Value 2004-2008
  • Table 6 OTC Healthcare Brand Shares by Value 2005-2008
  • Table 7 Penetration of Private Label by Sector 2003-2008
  • Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
  • Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
  • Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
  • Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
  • Table 12 Sales of Analgesics by Subsector: Value 2003-2008
  • Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008
  • Table 14 Herbal vs Standard Topical Analgesics 2003-2008
  • Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2008
  • Table 16 Analgesics Company Shares by Value 2004-2008
  • Table 17 Analgesics Brand Shares by Value 2005-2008
  • Table 18 Forecast Sales of Analgesics by Subsector: Value 2008-2013
  • Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013